KBIO LABS Inc. (KOSDAQ:038530)
South Korea flag South Korea · Delayed Price · Currency is KRW
999.00
+39.00 (4.06%)
At close: Aug 26, 2026

KBIO LABS Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
92,08287,31276,51427,32531,1298,722
Other Revenue
-----0-
92,08287,31276,51427,32531,1298,722
Revenue Growth
57.60%14.11%180.02%-12.22%256.89%52.80%
Cost of Revenue
78,76874,79564,85423,73027,4576,823
Gross Profit
13,31412,51711,6603,5953,6711,899
Selling, General & Admin
8,7188,5648,2573,6953,0015,986
Research & Development
1,3211,3211,132---
Amortization of Goodwill & Intangibles
30.3919.94255.52333.9333.958.35
Other Operating Expenses
235.28224.22273.2765.0280.58150.43
Operating Expenses
11,89811,76112,7704,2123,2186,986
Operating Income
1,416755.63-1,110-616.78453.41-5,087
Interest Expense
-49.34-53.95-78.02-60.82-1,207-1,781
Interest & Investment Income
1,6111,6471,843838.47995.31929.97
Currency Exchange Gain (Loss)
-136.42-133.92995.810.75-2.26-0.32
Other Non Operating Income (Expenses)
10.355.77198.1916,366-1,45758.91
EBT Excluding Unusual Items
2,8522,2201,84916,527-1,217-5,880
Gain (Loss) on Sale of Investments
-6,149-7,094-7,820-28,301-5,757-10,705
Gain (Loss) on Sale of Assets
2.734.480.79-26.7414.28-
Asset Writedown
--12.01-3,890--54.46-
Other Unusual Items
----17.45--
Pretax Income
-3,294-4,881-9,861-11,817-7,015-16,585
Income Tax Expense
162.07162.07132.3---
Earnings From Continuing Operations
-3,456-5,043-9,993-11,817-7,015-16,585
Earnings From Discontinued Operations
-38,268---857.05-650.4-2,881
Net Income to Company
-41,725-5,043-9,993-12,674-7,665-19,466
Minority Interest in Earnings
26,8421,8443,202---
Net Income
-14,883-3,200-6,791-12,674-7,665-19,466
Net Income to Common
-14,883-3,200-6,791-12,674-7,665-19,466
Net Income Growth
------
Shares Outstanding (Basic)
232323201815
Shares Outstanding (Diluted)
232323201815
Shares Change
0.12%-13.03%12.29%17.81%737.44%
EPS (Basic)
-643.85-138.51-294.01-620.16-421.16-1260.03
EPS (Diluted)
-645.34-140.00-295.00-621.94-421.16-1261.50
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
5,2368,160-190.34-1,4713,768-1,213
Free Cash Flow Per Share
226.53353.27-8.24-71.98207.05-78.51
Gross Margin
14.46%14.34%15.24%13.16%11.79%21.77%
Operating Margin
1.54%0.86%-1.45%-2.26%1.46%-58.33%
Profit Margin
-16.16%-3.67%-8.88%-46.38%-24.62%-223.18%
Free Cash Flow Margin
5.69%9.35%-0.25%-5.38%12.11%-13.91%
EBITDA
2,3961,693-25.92-125.741,045-4,413
EBITDA Margin
2.60%1.94%-0.03%-0.46%3.36%-50.60%
D&A For EBITDA
979.66937.551,084491.03591.58674
EBIT
1,416755.63-1,110-616.78453.41-5,087
EBIT Margin
1.54%0.86%-1.45%-2.26%1.46%-58.33%
Advertising Expenses
-51.2645.9440.931,087